Update your location to show providers, locations, and services closest to you.
Dr. Milner's research focus is graft manipulation. The utilization of graft manipulation permits decreased morbidities and improved quality of life in stem cell transplant recipients.
This study will assess the safety, efficacy, and feasibility of ⍺/β CD3+ T-cell and CD19+ B-cell depletion in allogeneic stem cell transplantation in patients with acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), juvenile…
This is a follow-up trial to NYMC 526 (NCT01461837) to assess the safety, efficacy and toxicity of administering Defibrotide prophylaxis for high-risk sickle cell or beta thalassemia patients undergoing a familial haploidentical allogeneic stem cell…
Severe Aplastic Anemia (SAA) is a rare condition in which the body stops producing enough new blood cells. SAA can be cured with immune suppressive therapy or a bone marrow transplant. Regular treatment for patients with aplastic anemia who have a…
6 publications
2023
Blood
PubMed • Publisher's site2022
Cureus
Publisher's site2022
Bone Marrow Transplant
Publisher's site2021
Bone Marrow Transplant
Publisher's site2018
Pediatric Blood Cancer
Publisher's site